Publications by authors named "Diana Torres-Lopez"

Background Some breast cancer cases are related to inherited mutations, and this is the reason why early mutation screening is emerging as an area of focus for cost-effective care. However, breast cancer-related mutations vary according to race, ethnicity, geographic origin, and healthcare access. Surveillance for familial breast cancer is not performed routinely in Colombia.

View Article and Find Full Text PDF

Objectives: Previous studies showed that noggin gene () sequence alterations, as well as epigenetic factors, could influence mandibular development. The aim of this study was to analyze clinical characteristics, gene sequences, and promoter methylation sites in patients with mandibular micrognathism.

Materials And Methods: A total of 35 individuals of five Colombian families were subject to clinical and cephalometric analysis for mandibular micrognathism.

View Article and Find Full Text PDF

Background: Inherited mutations in the breast cancer susceptibility genes and () confer high risks of breast and ovarian cancer. In Colombian Hispanic families, four common founder mutations have previously been identified. Because nothing is known about the contribution of germline mutations to early-onset and hereditary breast and/or ovarian cancer in Afro-Colombians, we conducted the first study on 60 patients with early-onset and familial breast cancer in this population.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Diana Torres-Lopez"

  • Diana Torres-Lopez's research focuses on the genetic and clinical aspects of breast cancer and mandibular micrognathism, emphasizing the importance of mutation screening and genetic predispositions in different populations.
  • Her studies reveal significant racial and ethnic variations in breast cancer mutations, particularly highlighting the lack of routine surveillance for familial breast cancer in Colombia.
  • In her work on mandibular micrognathism, she explores the impact of genetic alterations and promoter methylation in patients, providing insights into the clinical characteristics of this condition in Colombian families.